Nabulsi Azmi
Related Filers (1)
Ownership (19)
4
Monday, 1/22/2024
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/3/2023
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 7/17/2023
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/11/2023
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/20/2023
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/2/2022
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/16/2022
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/21/2022
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/4/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 4/5/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/3/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/3/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/29/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/5/2021
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/3/2020
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/3/2020
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
Phathom Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 10/24/2019
Phathom Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities